期刊文献+

脓毒症导致多器官功能障碍综合征相关危险因素分析 被引量:18

Risk Factors of Multiple Organ Dysfunction Syndrome Caused by Sepsis
在线阅读 下载PDF
导出
摘要 目的探讨脓毒症患者发展为多器官功能障碍综合征(MODS)的相关危险因素。方法选取2006年8月—2009年12月收治的196例脓毒症患者,分为脓毒症组153例和MODS组43例,回顾性分析其临床资料,进行单因素分析并行二元变量Logistic逐步回归筛选相关危险因素。结果脓毒症组死亡7例(4.6%),MODS组死亡27例(62.8%),两组比较差异有统计学意义(P<0.05)。共88份标本分离出病原菌,其中G-66例,G+17例,混合感染5例。MODS组患者年龄、急性生理学及慢性健康状况评分系统(APACHEⅡ)评分升高、合并慢性病、血肌酐水平升高、动脉血pH值、平均动脉压、细菌培养阳性、存在电解质紊乱、血糖水平较脓毒症组均明显升高,差异有统计学意义(P<0.05)。Logistic回归分析示APACHEⅡ评分升高、合并慢性病、血肌酐水平升高、细菌培养阳性是MODS发生的危险因素(P<0.05)。结论 APACHEⅡ评分升高、合并慢性病、血肌酐水平升高、细菌培养阳性等促进脓毒症患者发展为MODS,早期监测这些因素并采取及时有效的控制措施可以提高脓毒症患者治愈率,降低病死率。 Objective To explore the risk factors of multiple organ dysfunction syndrome(MODS)caused by sepsis.Methods The clinical data of 196 septic patients who were treated in our department from August 2006 to December 2009 were retrospectively analyzed.The univariate analysis and binary Logistic regression analysis were performed to screen the associated risk factors.Results Of these 196 patients,153 patients(78.1%)suffered from sepsis,among whom 7 patients(4.6%)died;43 patients(21.9 %)had MODS,among whom 27 patients(62.8%)died.The mortality rate was significantly different between the two groups(P〈0.05).Univariate analysis showed that the risk factors included age,APACH Ⅱscore,serum creatinine,blood pH level,mean arterial pressure,blood sugar,chronic diseases,germiculture results,and electrolyte imbalance(P〈0.05).Binary Logistic regression analysis identified four significant risk factors,which were APACH Ⅱscore,chronic diseases,creatinine,and germiculture.Conclusion APACH Ⅱ score,chronic diseases,serum creatinine,and positive germiculture results are risk factors of MODS caused by sepsis.
出处 《中国全科医学》 CAS CSCD 北大核心 2010年第32期3591-3593,共3页 Chinese General Practice
关键词 脓毒症 多器官功能衰竭 危险因素 Sepsis Mutiple organs failure Risk factors
  • 相关文献

参考文献11

  • 1La Rovere JM,Jeffries HE,Sachdeva RC,et al.Databases for assessing the outcomes of the treatment of patients with congenital and paediatric cardiac disease the perspective of critical care[J].Cardiol Young,2008,18 (Suppl 2):130-136.
  • 2郭维.脓毒症的临床表现、主要并发症[J].中国社区医师,2009,25(12):7-7. 被引量:2
  • 3Shapiro N,Howell MD,Bates DW,et al.The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection[J].Ann Emerg Med,2006,48(5):591-592.
  • 4Bates DW,Yu DT,Black E,et al.Resource utilization among patients with sepsis syndrome[J].Infect Control Hosp Epidemiol,2003,24(1):62-70.
  • 5周荣斌,周高速,郭凯.2008年严重脓毒症和脓毒性休克治疗指南简读[J].中国急救医学,2008,28(3):226-229. 被引量:81
  • 6胡皓夫.儿童严重脓毒症及感染性休克血管活性药物的应用评价[J].中国全科医学,2009,12(4):265-267. 被引量:12
  • 7Marshall JC,Cook DJ,Christou NV,et al.Multiple organ dysfunction score:a reliable descriptor of a complex clinical outcome[J].Crit Care Med,1995,23(10):1638-1652.
  • 8Delling RP,Leve MM,Carlet JM,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Crit Care Med,2008,36 (1):296-327.
  • 9周荣斌,周高速,郭凯,刘宇.2008年成人严重脓毒症和脓毒性休克治疗指南解读(1)[J].中国全科医学,2008,11(9):727-728. 被引量:21
  • 10Dellinger RP,Carlet JM,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med,2004,32 (10):858-873.

二级参考文献14

  • 1宋国维.关于《儿科感染性休克(脓毒性休克)诊疗推荐方案》的几个问题[J].中国小儿急救医学,2007,14(1):15-18. 被引量:7
  • 2刘明伟,苏美仙,黄青青.脓毒症的免疫抑制及治疗策略[J].中国全科医学,2007,10(8):671-673. 被引量:7
  • 3Duck GL, Briedis JH, Weaver RA, et al. Renal support in critically ill patients : low - dose dopamine or low - dose dobutamine [ J ]. Crit Care Med, 1994, 22 (12) : 1919 -1925.
  • 4Natalini G, Schivalocchi V, Rosano A, et al. Norepinephrine and metaraminol in septic shock: a comparison of the hemodynamic effects [J]. Intensive Care Med, 2005, 31 (5) : 634 -637.
  • 5Melendez E, Baehur R. Advances in the emergency management of pediatric sepsis [J]. Curr Opin Pediatr, 2006, 18:245 -253.
  • 6Dries DS. Vasoactive drug support in septic dhock [J]. Shick, 2006, 26 (5): 529-530.
  • 7Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign : guidelines for management of severe sepsis and septic shock [ J ]. Crit Care Med, 2004 , 32 (3): 858-873.
  • 8Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics [J]. Pediatr Crit Care Med, 2005, 6: 2-8.
  • 9Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Compaign : international guidelines for management of severe sepsis and septic shock: 2008 [J]. Crit Care Med, 2008:36 (1): 296-327.
  • 10Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock[J]. Crit Care Med,2004, 32:858 - 873.

共引文献112

同被引文献199

引证文献18

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部